Author: admin

Small Molecule Immunomodulators Market Revenue Share Study In The New Analysis By Leading Research Firm

“Small Molecule Immunomodulators Market”
Small Molecule Immunomodulators Market is valued at US$ 170.74 Bn in 2023, and it is expected to reach US$ 270.77 Bn by 2031, with a CAGR of 6.07% during the forecast period of 2024-2031.

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Global Small Molecule Immunomodulators Market – (By Product (Disposable, Reusable), By Application (Colorectal, Thoracic, Orthopedic, Ophthalmology, Neurosurgery, Cardiac Surgery, Gynecology, Others), By End User (Hospitals, Ambulatory Surgical Centers, Clinics, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031.”

According to the latest research by InsightAce Analytic, the Global Small Molecule Immunomodulators Market is valued at US$ 170.74 Bn in 2023, and it is expected to reach US$ 270.77 Bn by 2031, with a CAGR of 6.07% during the forecast period of 2024-2031.

 

Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/2307

 

Small molecule immunomodulators are compounds with low molecular weights that can influence the immune system’s function. Small molecules can easily penetrate cell membranes and act on intracellular targets, unlike larger biological drugs, which are often proteins or antibodies. These compounds have the capacity to modulate immune responses and are of interest for therapeutic applications in various immune-related disorders. The medical industry’s small molecule immunomodulators market is a specialist sector providing sets of medical supplies, equipment, and accessories specially made for particular surgeries or medical procedures. These kits increase productivity, lower the chance of error, and guarantee that all required supplies are on hand to streamline healthcare procedures. Healthcare providers are searching for effective solutions, such as customized procedure kits, in response to the increased emphasis on cost-effective healthcare delivery.

 

Further propelling market expansion are developments in medical technology that are making it possible to create more customized kits. Additional strategies for business development include diversifying product offerings and expanding into emerging markets. Custom procedure kits are essential to achieving the goals of patient safety and efficiency in the healthcare sector, and they present chances for innovation and expansion. Moreover, the hurdle is in the customization process itself, which necessitates exact cooperation between makers of the kits and healthcare professionals to customize each kit to the unique requirements of various treatments. There are plenty of business prospects in the market, given this changing scenario. Businesses that can meet regulatory standards and offer high-quality, tailored kits at a reasonable price are expected to thrive.

 

 

List of Significant Players in the Small Molecule Immunomodulators Market:

  • Medline Industries, Inc.
  • Teleflex Incorporated
  • Boston Scientific Corporation
  • BD (Becton, Dickinson and Company)
  • Owens & Minor, Inc.
  • 3M
  • Moonlike Health Care
  • Cardinal Health, Inc.
  • B. Braun Melungeon AG
  • Halyard Health, Inc.
  • Smith & Nephew plc
  • Thermos Fisher Scientific Inc.
  • Terumo Corporation
  • Moonlike Health Care AB
  • Johnson & Johnson Services, Inc
  • Others

 

Market Dynamics:

 

Drivers- 

The enhanced medical technology is responsible for the demand for custom procedure kits in the industry. The development of highly specialized and effective custom kits is made possible by advancements in surgical instruments and medical technologies. In order to guarantee that they have access to the newest, most advanced instruments and can improve patient outcomes and safety, healthcare providers look for these kits. Custom kits’ growing reliance on cutting-edge technology has emerged as a key factor in addressing the changing demands of contemporary surgical and healthcare practices. Furthermore, the market for small-molecule immunomodulators is experiencing a notable increase in demand due to the trend of outpatient surgery. The demand for effective, portable, and procedure-specific bespoke kits is rising as more surgical operations are being performed in outpatient clinics and institutions rather than in more conventional hospital settings. 

 

Challenges:

The market for small molecule immunomodulators is constrained by surgical complexity since highly specialized and sophisticated procedures may lend themselves poorly to standardization within custom kits. It is difficult to design universally applicable kits because these intricate surgeries frequently call for various specialized tools and supplies. As a result, medical facilities might decide to use conventional purchasing techniques, which would prevent custom kits from being widely used. The actual customization process presents another difficulty since it necessitates close collaboration between kit producers and healthcare professionals in order to customize each kit to the unique requirements of various treatments. Market demand may be constrained by customization constraints when it comes to meeting complex surgical needs, especially in specialist medical disciplines.

 

 

Regional Trends:

The North American small molecule immunomodulators market is expected to register a major market share. The market for small-molecule immunomodulators in North America is seeing several noteworthy trends. The market for customized kits is being driven by the rising use of outpatient surgical procedures and the increasing focus on providing healthcare at a reasonable cost. The market is further stimulated by advanced hospital infrastructure and a heavy emphasis on infection control techniques. Besides, Asia Pacific had a considerable market share. Notable trends are being observed in the custom procedure kits market in the region. The demand for customized treatment kits is rising as the healthcare infrastructure grows and access to medical services improves. Custom kit suppliers are benefiting from the growth in outpatient operations and speciality medical treatments occurring in nations like China and India. 

 

Curious About This Latest Version Of The Report? Enquiry Before Buying: https://www.insightaceanalytic.com/enquiry-before-buying/2307

 

Recent Developments:

 

  • In Feb 2022, Remix Therapeutics (Remix) declared a strategic partnership with Janssen Pharmaceutica NV, a subsidiary of Johnson & Johnson. The collaboration aims to discover and develop small molecule therapeutics that manipulate RNA processing, utilizing Remix’s REMaster drug discovery platform. The partnership was facilitated by Johnson & Johnson Innovation.

 

Segmentation of Small Molecule Immunomodulators Market-

By Product

  • Disposable
  • Reusable

By Application

  • Colorectal
  • Thoracic
  • Orthopedic
  • Ophthalmology
  • Neurosurgery
  • Cardiac Surgery
  • Gynecology
  • Others

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Others

By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

 

For More Customization @ https://www.insightaceanalytic.com/customisation/2307

Media Contact
Company Name: InsightAce Analytic Pvt. Ltd
Contact Person: Diana D’Souza
Email: Send Email
Country: United States
Website: https://www.insightaceanalytic.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Small Molecule Immunomodulators Market Revenue Share Study In The New Analysis By Leading Research Firm

Microcrystal Electron Diffraction (MicroED) Service Market – Recent Innovations and Upcoming Trends Analysis

“Microcrystal Electron Diffraction (MicroED) Service Market”
Microcrystal Electron Diffraction (MicroED) Service Market is valued at US$ 2.04 Bn in 2023, and it is expected to reach US$ 3.10 Bn by 2031, with a CAGR of 5.52% during the forecast period of 2024-2031.

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Global Microcrystal Electron Diffraction (MicroED) Service Market – (By Type (Single Crystal Cultivation, No Single Crystal Cultivation Required), By Application (Proteins, Small Molecules, Other)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031.”

According to the latest research by InsightAce Analytic, the Global Microcrystal Electron Diffraction (MicroED) Service Market is valued at US$ 2.04 Bn in 2023, and it is expected to reach US$ 3.10 Bn by 2031, with a CAGR of 5.52% during the forecast period of 2024-2031.

 

Microcrystal electron diffraction (MicroED) service is an analytical method that determines the atomic structure of microcrystalline samples. It is used in structural biology, chemistry, and materials science. MicroED, are in high demand due to the expanding market. Drug development and molecular biology benefit greatly from the method’s capacity to examine the structure of both biological macromolecules and chemical small molecules, which is expected to boost the growth of the global microcrystal electron diffraction (MicroED) service market. Moreover, the resolution and accuracy of analyses have been improved by innovations in MicroED technology, which include better sample preparation, data gathering, and structural determination. Due to these improvements, MicroED is now a more appealing option for conducting in-depth structural analyses of microcrystalline samples. Favorable government initiatives to promote the use of microcrystal electron diffraction (MicroED) service owing to increased use of MicroED in industries such as pharmaceuticals and the study of materials, along with a strong scientific community, are driving this expansion and ultimately increasing competition, thereby boosting the market growth.

 

Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/2331

 

List of Prominent Players in the Microcrystal Electron Diffraction (MicroED) Service Market:

 

  • Viva Biotech
  • NanoImaging Services
  • XtalPi Inc
  • Wuxi Biortus Biosciences Co. Ltd.
  • ReadCrystal
  • Creative Biostructure
  • Shuimu Biosciences
  • NovAliX
  • ELDICO Scientific
  • Thermo Fisher Scientific
  • Other prominent players

 

Market Dynamics:

 

Drivers- 

Growing demand for rising in popularity throughout industries including medicine, chemistry, biology, and technology advancement is a key factor estimated to drive growth of the target market. Because of its capacity to give precise structural insights at atomic or near-atomic resolution, microED is gaining popularity in domains like pharmaceuticals, science of materials, and biological studies. When it comes to creating new materials and discovering new drugs, this is essential is another factor expected to contribute significant revenue share in the global microcrystal electron diffraction (MicroED) service market. Additionally, new innovations and applications are created through collaborations between universities, labs, and businesses in the MicroED service industry. Investments in research facilities also contribute to the expansion of the global microcrystal electron diffraction (MicroED) service market.

 

Challenges:

 

The prime challenge is high startup cost and lack of expert individuals in developing countries, predicted to reduce the growth of the microcrystal electron diffraction (MicroED) service market. However, obtaining the electron microscope equipment required for MicroED requires a high initial expenditure. The operating costs, which include things like upkeep and the cost of specialized workers needed to execute the studies are factors expected to hamper the overall growth of the microcrystal electron diffraction (MicroED) service market over the coming years. Furthermore, because of their relative scarcity, microED services pose a significant barrier to entry for academic institutions lacking the resources or partnerships to make use of them. In emerging areas or among academics who aren’t familiar with the method, this can slow down the adoption of MicroED service market in the coming years.

 

Regional Trends:

 

The North American microcrystal electron diffraction (MicroED) service market is expected to register a large market revenue share and it will grow at a high CAGR in the near future. Because influential people and state-of-the-art research facilities are located there. Companies from all over the world have made their mark on the market, and mergers and acquisitions have helped shape the dynamic between them, which are factors expected to proliferate the growth of the microcrystal electron diffraction (MicroED) service market in the region. Besides, Europe had a considerable share in the market due to innovations in sample preparation, data collecting, and structural determination, which are driving forces in the market. Moreover, the existance of key market players and the expanding use of MicroED in industries such as pharmaceuticals and materials science, along with the robust research facilities in the area, are driving this expansion in the region and provide the opportunity for growth of the global microcrystal electron diffraction (MicroED) service market.

 

Curious About This Latest Version Of The Report? Enquiry Before Buying: https://www.insightaceanalytic.com/enquiry-before-buying/2331

 

Recent Developments:

 

  • In June 2023, Viva Biotech Ltd. And DP Technology Co., Ltd. joined forces to advance RNA-targeted small molecule drug discovery based on AI4S. This strategic partnership will allow them to fully utilize their respective resources and work closely together, taking advantage of the synergies and complementarities between their businesses and technologies.

 

  • In August 2023, NanoImagingServices introduced new cryo-TEM services to assist in the characterization of biologics in a way that complies fully with GMP regulations. With the use of cryo-TEM services, biotech companies can learn more about the reliability and uniformity of their production processes and final goods. The level of detail that scientists can see and comprehend in their new goods is unmatched.  

 

Segmentation of Microcrystal Electron Diffraction (MicroED) Service Market-

Microcrystal Electron Diffraction (MicroED) Service Market By Type-

  • Single Crystal Cultivation
  • No Single Crystal Cultivation Required

Microcrystal Electron Diffraction (MicroED) Service Market By Application-

  • Proteins
  • Small Molecules
  • Other

Microcrystal Electron Diffraction (MicroED) Service Market By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

 

For More Customization @ https://www.insightaceanalytic.com/customisation/2331

Media Contact
Company Name: InsightAce Analytic Pvt. Ltd
Contact Person: Diana D’Souza
Email: Send Email
Country: United States
Website: https://www.insightaceanalytic.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Microcrystal Electron Diffraction (MicroED) Service Market – Recent Innovations and Upcoming Trends Analysis

Lentiviral Vector (LVV) CDMO Services Market Report Explores Future Scope and Latest Trends Analysis Report

“Lentiviral Vector (LVV) CDMO Services Market”
Lentiviral Vector (LVV) CDMO Services Market is expected to develop with a CAGR of 8.7% during the forecast period of 2024-2031.

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Global Lentiviral Vector (LVV) CDMO Services Market – (By Type (IIT Grade, IND Grade, Clinical Trial Grade, Commercial Production Grade), By Application (Biopharmaceutical Company, Academic Scientific Research Institution)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031.”

According to the latest research by InsightAce Analytic, the Global Lentiviral Vector (LVV) CDMO Services Market is expected to develop with a CAGR of 8.7% during the forecast period of 2024-2031.

 

LVV CDMOs play a critical role in the gene therapy and cell therapy fields by providing the specialized expertise and infrastructure required to produce high-quality lentiviral vectors. Their services enable biotechnology and pharmaceutical companies to advance their therapeutic candidates through preclinical and clinical development towards commercialization, ultimately aiming to bring new treatments to patients with genetic diseases, cancers, and other conditions.

 

Organizations can benefit from healthcare management services by contracting with an outside company to take care of day-to-day operations and maintenance at their buildings and other less crucial tasks. The MSO provider’s offerings included hard services, business support services, and energy management services. Modernizing office premises and expanding cities have raised the need for healthcare services. In addition, customer companies are improving their operations by reducing their infrastructure and procedures. The increasing efficiency of business processes depends on the facilities’ ability to work as expected. Healthcare service providers have their jobs in energy management cut out for them. However, the poor retention of skilled workforce is a limitation on the growth of the worldwide lentiviral vector (LVV) CDMO services market, making it one of the most difficult markets to maintain a stable workforce.

 

Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/2374

 

List of Prominent Players in the Lentiviral Vector (LVV) CDMO Services Market:

  • Thermo Fisher Scientific
  • GenScript ProBio
  • Hillgene
  • Charles River Laboratories
  • Ubrigene
  • Obio Technology (shanghai)
  • Genesail Biotech (Shanghai)
  • Wuxi Apptec
  • Porton Advanced Solutions
  • Pharmaron
  • Asymchem Laboratories (Tianjin)
  • Merck
  • VectorBuilder
  • Yposkesi
  • Flash Therapeutics
  • VIVEBiotech
  • Miltenyi Bioindustry
  • Genezen
  • Miltenyi Biotec
  • Exthera,
  • Catalent 
  • Other Market Players

 

Market Dynamics:

 

Drivers- 

The growing demand for the lentiviral vector (LVV) CDMO services market is fueled because the industry is positioned advantageously to profit from increases in global infrastructure spending. Most work done and new business generated in this sector is associated with enhancing preexisting structures. Governments in these countries are therefore recruiting private organizations, including service providers and several foreign companies, to assist in the upkeep of a green and clean infrastructure.

 

Challenges:

The prime challenge is insufficient technological knowledge, a shortage of competent individuals, and a lack of norms and protocol because of lockdowns and isolation in emerging countries, which is predicted to slow the growth of the lentiviral vector (LVV) CDMO services market—restrictions on final purification and the vectors’ inability to scale. As a result of increased genomics funding and strategic moves by major industry players, the worldwide lentiviral vector market is setting up for future growth. Stringent regulatory limits and undesirable effects provide possible hurdles to expanding lentiviral vector products. 

 

Regional Trends:

The North American lentiviral vector (LVV) CDMO services market is anticipated to record a large market share in revenue. It is projected to grow at a high CAGR in the near future because of the growing research and development activities of both small and major companies. Businesses in North America are thriving because their leaders are adopting integrated enterprise and business solutions, which allow for more adaptability and speed in daily operations. Besides, Europe had a considerable share in the market because the number of patients and R&D initiatives in this sector is growing.

 

Curious About This Latest Version Of The Report? Enquiry Before Buying: https://www.insightaceanalytic.com/enquiry-before-buying/2374

 

Recent Developments:

 

  • In April 2023, Yposkesi introduced LentiSure, a platform for producing Lentiviral (LV) vectors that has been optimized to achieve higher yields. The introduction of the new LV platform has enhanced the ability of CAR-T developers to advance clinical development and commercialize cell and gene therapy pipelines more effectively.

 

  • In Sept 2023, Charles River Laboratories International, Inc. introduced its Lentivation™ platform for generating lentiviral vectors (LVV). The technology possessed the capacity to diminish LVV manufacturing timelines for gene and gene-modified cell therapies by as much as 60 percent, resulting in less than seven months compared to conventional manufacturing processes.

 

Segmentation of Lentiviral Vector (LVV) CDMO Services Market-

By Type-

  • IIT Grade
  • IND Grade
  • Clinical Trial Grade
  • Commercial Production Grade

By Application-

  • Biopharmaceutical Company
  • Academic Scientific Research Institution

By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa

 

For More Customization @ https://www.insightaceanalytic.com/customisation/2374

Media Contact
Company Name: InsightAce Analytic Pvt. Ltd
Contact Person: Diana D’Souza
Email: Send Email
Country: United States
Website: https://www.insightaceanalytic.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Lentiviral Vector (LVV) CDMO Services Market Report Explores Future Scope and Latest Trends Analysis Report

Hospital Energy Management Solutions Market 2024-2031 Exclusive Study Report By Leading Research Firm

“Hospital Energy Management Solutions Market”
Global Hospital Energy Management Solutions Market is expected to raise with a CAGR of 8.39% during the forecast period of 2024-2031.

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Global Hospital Energy Management Solutions Market – (By Product (Equipment, Control System), By Application (Hospital Logistics Power, Hospital Emergency Logistics Power, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031.”

According to the latest research by InsightAce Analytic, the Global Hospital Energy Management Solutions Market is expected to raise with a CAGR of 8.39% during the forecast period of 2024-2031.

 

Hospital energy management solutions encompass a range of strategies and technologies designed to optimize energy use, reduce prices, and minimize the environmental footprint of healthcare facilities. Given the continuous operation and significant energy demands of hospitals, which include lighting, heating, cooling, medical equipment, and sterilization processes, effective energy management is crucial. The growing acknowledgment of the significance of deploying energy management system (EMS) solutions within residential, commercial, and industrial sectors is set to drive market expansion in the coming years. Particularly, the industrial and commercial domains are anticipated to embrace EMS solutions owing to their significant energy consumption levels. Increasing awareness about energy efficiency and sustainability drives the adoption of energy management solutions in hospitals. Hospitals are recognizing the importance of reducing energy consumption not only to cut costs but also to minimize their environmental footprint.

 

Moreover, regulatory initiatives and incentives aimed at promoting energy efficiency encourage hospitals to invest in energy management solutions. Technological advancements, such as the development of smart building systems and IoT-enabled devices, also contribute to the growth of the market by offering more sophisticated energy management capabilities. However, the high upfront cost associated with implementing energy management solutions in hospitals is an increasing challenge. Many healthcare facilities operate on tight budgets, making it difficult to allocate funds for large-scale infrastructure upgrades. Many healthcare facilities operate on tight budgets, making it difficult to allocate funds for large-scale infrastructure upgrades. 

 

Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/2349

 

List of Prominent Players in the Hospital Energy Management Solutions Market:

  • Siemens AG
  • Schneider Electric SE
  • Johnson Controls International plc.
  • Honeywell International Inc.
  • GE Healthcare
  • Trane Technologies plc
  • ABB Ltd.
  • Cerner Corporation
  • Medical Facilities Management
  • Veolia Environment SA
  • Futronix
  • Pacific Controls
  • Distech
  • GE-Alstom Grid
  • Other Prominent Players

 

Market Dynamics:

 

Drivers- 

Growing demand for bioethanol as an alternative fuel in automotive the swift expansion of the healthcare and retail sectors has spurred a heightened demand for EMS solutions. Within these sectors, there’s an anticipation of increased investment propelled by the commercialization of innovative products like SCADA and others. Across various industries, the uptake of EMS is projected to rise, facilitated by its capacity to gather insights into power consumption on a departmental level. Technological advancements such as small-signal analysis within EMS is expected to drive adoption and contribute to carbon emission reduction efforts. Moreover, companies such as Schneider Electric, IBM Corporation, and Honeywell International Inc. have integrated data analytics software into their existing energy management modules, enhancing data monitoring efficiency. Additionally, these entities have tailored sector-specific EMS software to deliver more effective solutions, thereby stimulating the development of new products within this market.

 

Challenges:

The Hospital Energy Management Solutions Market faces several challenges as it endeavors to optimize energy usage within healthcare facilities. One significant restraint is the complexity of integrating energy management systems within existing hospital infrastructure. Retrofitting older buildings with modern energy-efficient technologies can be costly and disruptive, requiring careful planning and coordination to minimize downtime and inconvenience to patients and staff. Additionally, healthcare facilities operate 24/7, resulting in continuous energy demand and making it challenging to implement energy-saving measures without affecting essential services. Another challenge is the variability in energy usage patterns within hospitals, with different departments having distinct energy needs and usage profiles. This necessitates tailored energy management strategies to address diverse requirements efficiently. Moreover, budget constraints may hinder investment in comprehensive energy management solutions despite the potential long-term cost savings.

 

Regional Trends:

Hospital Energy Management Solutions is projected to secure a considerable market share in the North American regional market, with forecasts indicating its leadership in the global market. This dominance is driven by the increasing adoption of Energy Management Systems (EMS) across diverse sectors, including retail, power, and manufacturing, among others. Moreover, substantial growth is expected in the European market during the forecast period, propelled by favorable government initiatives such as Electricity and monitoring systems, along with neighborhood-oriented brokerage. The UK, Germany, and France are expected to witness significant growth, driven by the escalating demand to minimize power losses in these regions. Additionally, Asia Pacific has held a significant share of the market, attributed to beneficial governmental strategies and initiatives, alongside support from countries like China and India, offering incentives such as tax breaks and accelerated industrialization efforts. Furthermore, significant growth is anticipated in the Middle East and Africa throughout the forecast period, primarily fueled by rapid industrialization in the region. Heightened environmental consciousness in the Middle East has also led to a prioritization of energy consumption management.

 

Curious About This Latest Version Of The Report? Enquiry Before Buying: https://www.insightaceanalytic.com/enquiry-before-buying/2349

 

Recent Developments:

  • In June 2022, Veolia enhanced energy efficiency at the Royal Berkshire Hospital in Reading by extending the current contract by 15 years. The £9.7 million project involved installing hydrogen-ready boilers at the 740-bed Hospital, marking a significant step towards achieving a zero-carbon future. This technology is believed to be the first of its kind used in the NHS. By implementing more efficient boilers, minimizing distribution heat losses, and enhancing control of heating and hot water systems, the hospital was able to conserve around 3.8 gigawatt-hours of gas and 850 metric tons of carbon annually.

 

  • In January 2020, Schneider Electric introduced an upgraded version of the traditional Fusebox, marketed as the Energy Center product, catering to homeowners seeking enhanced power management solutions. This new offering is part of Schneider Electric’s broader range of Square D home energy management devices aimed at homeowners.

 

Segmentation of Hospital Energy Management Solutions Market-

 

By Product-

  • Equipment
  • Control System

By Application,

  • Hospital Logistics Power
  • Hospital Emergency Logistics Power
  • Others.

By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

 

For More Customization @ https://www.insightaceanalytic.com/customisation/2349

Media Contact
Company Name: InsightAce Analytic Pvt. Ltd
Contact Person: Diana D’Souza
Email: Send Email
Country: United States
Website: https://www.insightaceanalytic.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Hospital Energy Management Solutions Market 2024-2031 Exclusive Study Report By Leading Research Firm

Digital Adoption Platform (DAP) Market Future Scope and Latest Trends Analysis Report

“Digital Adoption Platform (DAP) Market”
Digital Adoption Platform (DAP) Market is estimated to exhibit a CAGR of 17.59% during the forecast period.

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Global Digital Adoption Platform (DAP) Market Size, Share & Trends Analysis Report By Deployment Mode (Cloud-based DAP, On-premise based DAP), By Vertical (Information Technology (IT) and Telecom, Healthcare, Financial Service, Retail and E-commerce), Region, Market Outlook And Industry Analysis 2031”

 

The global digital adoption platform (DAP) market is estimated to exhibit a CAGR of 17.59% during the forecast period.

 

Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/2383

 

Digital adoption platforms streamline software learning for employees and users alike, making it easier to become proficient on any platform, web page, or application. The global digital adoption platform (DAP) market is anticipated to have significant expansion in the coming years, driven by factors such as there is a growing concern elevating the customer and staff experience, an increasing number of people living in urban areas, growing initiatives to digitize in developing nations, and, customer happiness. Moreover, market expansion is propelled by rising demands for labor efficiency and productivity and the ever-increasing complexity of digital technologies. Support systems that help users understand and use digital tools effectively are becoming more important as the complexity of these products continues to rise. The importance of a productive and efficient staff is growing across all sectors. However, it can be difficult and time-consuming to integrate new digital adoption platforms (DAP) with preexisting information and SMEs with smaller budgets; the implementation and ongoing maintenance costs of DAP solutions might be prohibitive, limiting the growth of the digital adoption platform (DAP) market. Furthermore, businesses cut down on training expenses by offering individualized instruction and rising productivity, propelling the digital adoption platform (DAP) industry and increasing market expansion.

 

List of Prominent Players in the Digital Adoption Platform (DAP) Market:

  • Whatfix
  • WalkMe
  • Stonly
  • Oracle
  • AppLearn
  • SAP
  • Userlane
  • Pendo
  • Knowmore
  • Appcues,

 

Market Dynamics:

Drivers-

The growing popularity of digital adoption platforms and technological progress are key factors expected to be driven by the growing popularity of online banking and the demand for better services to attract and retain customers to expand in the DAP market, and the BFSI industry must embrace digital technologies allowing greater client engagement and real-time assistance. Organizations can contribute to overall cost savings by reducing training expenses and increasing operational efficiency with the help of DAPs. Additionally, technological advancements like the Internet of Things and machine learning have improved the capacity of digital adoption platforms. These technologies make smart workflow optimization, predictive analysis, and continuous monitoring possible, decreasing operating expenses. As a result, the global market for digital adoption platforms (DAP)s continues to expand.

 

Challenges:

Rapidly changing technology, high cost, and the implementation of a new digital adoption platform are predicted to be challenges that will reduce the market’s growth. It can be challenging for many firms to implement a new DAP without causing disruptions to their operations because of their already established procedures and systems. Employees’ reluctance to change might further slowdown their implementation, especially if they see DAPs as adding complexity to their current processes or complicating things needlessly. In addition, the digital adoption platform cannot be adopted by all organizations due to the high initial investment and continuous expenses for training and support, hindering market growth during the next few years.

 

Regional Trends:

The North American digital adoption platform (DAP) market is expected to register a major market share in the revenue. It is projected to grow at a high CAGR in the near future. The rising demand for the high rate of digital adoption platform solutions is propelled by the need to improve staff efficiency and productivity. Additional factors that enhance the growth possibilities of the North American DAP market include important competitors and a supportive regulatory framework. The use of digital adoption platform systems by retailers and business providers is driven by consumer expectations for rapid, dependable, and state-of-the-art technology, which is expected to grow the region’s digital adoption platform (DAP) market. Besides, Europe has a substantial share of the digital adoption platform (DAP) market. They are in high demand due to the strong expansion of the economy, which in turn boosts consumer expenditure and spending increasingly money on digital adoption platform solutions. Increases in smartphone use, government programs encouraging digitization, and the overall expansion of digital adoption drive the market forward. There is a high need for a digital adoption platform because of the region’s big workforce, which requires effective solutions for training and recruiting.

 

Curious about this latest version of the report? @ https://www.insightaceanalytic.com/enquiry-before-buying/2383

 

Recent Developments:

  • In January 2024, Oracle and Amdocs, a top supplier of software and services to media and communications firms, announced the growth of their worldwide partnership to enable clients on their path to cloud and digital adoption through Oracle Cloud Infrastructure (OCI).
  • In February 2024, WalkMe Inc., a prominent provider of digital adoption solutions, announced that its WalkMe Digital Adoption Platform (DAP) is now available on the AWS Marketplace. This move allows WalkMe to reach a wider audience and gives customers easier access to its robust digital adoption solutions.

 

Segmentation of Digital Adoption Platform (DAP) Market-

By Deployment Mode-

  • Cloud-based DAP
  • On-premise based DAP

By Vertical-

  • Information Technology (IT) & Telecom
  • Healthcare
  • Financial Service
  • Retail & E-commerce
  • Others

By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

 

For More Customization @ https://www.insightaceanalytic.com/customisation/2383

Media Contact
Company Name: InsightAce Analytic Pvt. Ltd
Contact Person: Diana D’Souza
Email: Send Email
Country: United States
Website: https://www.insightaceanalytic.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Digital Adoption Platform (DAP) Market Future Scope and Latest Trends Analysis Report

Breast Cancer Core Needle Biopsy Market Reviews Analysis Report 2024

“Breast Cancer Core Needle Biopsy Market”
Breast Cancer Core Needle Biopsy Market is valued at US$ 697.3 Mn in 2023, and it is expected to reach US$ 1,042.3 Mn by 2031, with a CAGR of 5.34% during the forecast period of 2024-2031.

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Global Breast Cancer Core Needle Biopsy Market – (By Technology (MRI-based Breast Biopsy, Ultrasound-based Breast Biopsy, Mammography-based (Stereotactic) Breast Biopsy, CT-based Breast Biopsy, Other Image Based Breast Biopsy), By End-use (Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031.”

According to the latest research by InsightAce Analytic, the Global Breast Cancer Core Needle Biopsy Market is valued at US$ 697.3 Mn in 2023, and it is expected to reach US$ 1,042.3 Mn by 2031, with a CAGR of 5.34% during the forecast period of 2024-2031.

 

Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/2310

 

Core needle biopsies have several benefits compared to conventional surgical techniques, such as reduced invasiveness, quicker recovery, and cost-effectiveness. The market for core needle biopsies is projected to increase due to their vital role in early detection and enhanced patient outcomes, driven by the growing global awareness of early detection. During the Biopsy, tissue or fluid is surgically removed to examine it and determine whether any potential ailments exist. An analysis of the extracted tissue is conducted at a microscopic level to identify the existence of cancerous cells. 

 

Moreover, the market is growing due to breakthroughs in breast biopsy devices and technical improvements. However, the high price of breast biopsies and their long list of unfavourable side effects could prevent the business from growing. Additionally, the rising incidence of breast cancer has made vendor promotion opportunities crucial. Prominent industry participants prioritize broadening their product offerings and obtaining product approvals. Conferences are one of the many venues available to educate people about cancer and raise awareness of the disease.

 

List of Prominent Players in the Breast Cancer Core Needle Biopsy Market:    

  • Intact Medical Corporation
  • Ethicon Surgical Technologies.
  • Galling SRL
  • Leica Biosystems Nussle GmbH
  • Hologic, Inc
  • Argon Medical Devices
  • Encapsule Medical Devices LLC.
  • Cook Medical Incorporated
  • Becton Dickinson and Company
  • C.R. Bard, Inc.
  • Zenalux Biomedical, Inc., 
  • F. Hoffmann-La Roche Ltd., 
  • OncoCyte Corporation, 
  • Laboratory Corporation of America Holdings (LabCorp), 
  • Scion Medical Technologies, 
  • Planmed Oy, 
  • Aurora Imaging Technology Inc., 
  • Carestream Health, 
  • Cardinal Health, 
  • PerkinElmer
  • QIAGEN
  • Thermo Fisher Scientific
  • Medtronic
  • Danaher Corporation
  • Others

 

Market Dynamics:

Drivers- 

The increasing frequency of breast cancers and improvements in imaging and biopsy techniques are driving the market for breast biopsy instruments, which is expanding quickly. Innovations in breast biopsy tools and their increasing technical capabilities are driving market expansion. Still, market expansion may be constrained by the high cost of breast biopsy and its many unfavourable side effects. With the rising incidence of breast cancer, vendor advertising opportunities have become crucial. The primary goals of major market participants are diversifying their product offerings and obtaining product approvals. One can use a variety of forums, such as conferences, to increase awareness and disseminate the word about cancer.

 

Challenges:

The possibility of sample mistakes and ambiguous outcomes from core needle biopsy techniques is one important drawback. The size and location of the tumour may have an impact on the Biopsy’s accuracy in identifying breast cancer, which could result in confusing or false-negative results. The pain and discomfort that some patients feel during core needle biopsy treatments is another barrier. This may cause patients to become reluctant or anxious, which may affect their willingness to have the Biopsy done even if it is advised for diagnostic purposes. In addition, there are economic factors that influence market limitations. Accessibility may be restricted by the cost of core needle biopsy operations, including supplies, trained people, and post-biopsy care, especially in areas with scarce healthcare resources. 

 

Regional Trends:

The North America Breast Cancer Core Needle Biopsy market is expected to register as a major market. The two largest economies in the region, the United States and Canada, provide the majority of the market value in the region’s revenue. The growing medical tourism in the area supports the value of the current regional market. Besides, Asia Pacific had a considerable market share. The area’s quickly developing countries have invested in the construction of healthcare infrastructure, fueling the market’s expansion. Additionally, firms can purchase breast biopsy equipment in developing markets as more people become aware of breast biopsy treatments in the diagnostic market in these countries. The swift progress in medical technology in countries such as China, India, & South Korea has led to significant investments in state-of-the-art technologies (such as vacuum-assisted biopsy equipment and liquid breast biopsy) by hospitals and other breast care facilities. 

 

Curious About This Latest Version Of The Report? Enquiry Before Buying: https://www.insightaceanalytic.com/enquiry-before-buying/2310

 

Recent Developments:

 

  • In Jan 2021, Somatex Medical Technologies GmbH, a market leader in biopsy site markers and localization technologies, was acquired by Hologic, Inc. for an estimated $64 million, the company disclosed this morning. Hologic’s approach to offering an all-encompassing collection of groundbreaking solutions spanning the entire spectrum of breast health care was reinforced by the transaction.

 

Segmentation of Breast Cancer Core Needle Biopsy Market-

By Technology

  • MRI-based Breast Biopsy
  • Ultrasound-based Breast Biopsy
  • Mammography-based (Stereotactic) Breast Biopsy
  • CT-based Breast Biopsy
  • Other Image Based Breast Biopsy

By End-use

  • Hospitals & Diagnostic Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes”

By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

 

For More Customization @ https://www.insightaceanalytic.com/customisation/2310

Media Contact
Company Name: InsightAce Analytic Pvt. Ltd
Contact Person: Diana D’Souza
Email: Send Email
Country: United States
Website: https://www.insightaceanalytic.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Breast Cancer Core Needle Biopsy Market Reviews Analysis Report 2024

Air Traffic Control (ATC) Market to reach USD 13.5 Billion by 2027, at a CAGR of 8.4%

“Air Traffic Control (ATC) Market”
The Air Traffic Control (ATC) Market is estimated to be USD 9.0 billion in 2022 and is projected to reach USD 13.5 billion by 2027, at a CAGR of 8.4%.

The global Air Traffic Control (ATC) Market is poised for substantial growth in the coming years, according to the latest report by MarketsandMarkets. Estimated to be valued at USD 9.0 billion in 2022, the market is projected to reach USD 13.5 billion by 2027, exhibiting a robust Compound Annual Growth Rate (CAGR) of 8.4% during the forecast period.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=159216929

Air Traffic Control (ATC) Market

Key Segments in the Market:

By Component:

  • Hardware
  • Software
  • Services

 

By End-Use:

  • Commercial
  • Defense

 

By Sector:

  • Communication
  • Navigation
  • Surveillance

 

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

 

Inquire Before Buying @ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=159216929

Growth Drivers:

Several factors are driving the growth of the global Air Traffic Control market, including:

Rising Air Travel Demand: The increasing demand for air travel, driven by factors such as economic growth, rising disposable incomes, and expansion of tourism, is leading to higher air traffic volumes globally. This necessitates the modernization and expansion of air traffic control systems to ensure safe and efficient management of air traffic, thereby fueling market growth.

Technological Advancements: Advancements in technologies such as automation, artificial intelligence (AI), and data analytics are transforming the landscape of air traffic control systems. Innovative solutions that enhance situational awareness, improve communication, and optimize airspace utilization are being adopted to address the evolving needs of the aviation industry, driving market growth.

Government Initiatives: Governments worldwide are investing in the modernization and upgrade of their air traffic management infrastructure to enhance safety, efficiency, and capacity. Initiatives aimed at implementing advanced air traffic control systems, improving airspace management, and enhancing collaboration between stakeholders are driving market growth.

Challenges:

Despite the positive growth outlook, the global Air Traffic Control market faces certain challenges, including:

Complex Regulatory Environment: The air traffic control industry is subject to stringent regulatory standards and requirements, which can vary significantly across regions and jurisdictions. Compliance with regulatory mandates, certification processes, and interoperability standards poses challenges for market players, particularly in international markets.

Integration Complexity: Integrating new technologies and systems into existing air traffic control infrastructure can be complex and resource-intensive. Compatibility issues, interoperability challenges, and the need for seamless integration with legacy systems can hinder the adoption of advanced solutions, impacting market growth.

View detailed Table of Content here – https://www.marketsandmarkets.com/Market-Reports/air-traffic-control-equipment-market-159216929.html

Opportunities:

The market presents several opportunities for growth, including:

Modernization Initiatives: Ongoing modernization initiatives undertaken by governments and aviation authorities present opportunities for market players to provide innovative solutions that address the evolving needs of the industry. Investments in next-generation air traffic management systems, digitalization, and automation offer avenues for growth and expansion in the market.

Emerging Technologies: The emergence of technologies such as unmanned aerial vehicles (UAVs), urban air mobility (UAM), and satellite-based navigation systems presents new opportunities for the air traffic control market. Market players investing in research and development to develop solutions tailored to the needs of emerging aviation segments stand to capitalize on these opportunities.

Key Players:

Key Players Operating in the global Air Traffic Control Market include:

  • Thales Group
  • Raytheon Technologies Corporation
  • Indra Sistemas, S.A.
  • Saab AB
  • Lockheed Martin Corporation

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/air-traffic-control-equipment-market-159216929.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Air Traffic Control (ATC) Market to reach USD 13.5 Billion by 2027, at a CAGR of 8.4%

Gene Expression Analysis Market worth $6.2 billion by 2029

“Browse in-depth TOC on “Gene Expression Analysis Market” 436 – Tables 54 – Figures 369 – Pages”
Browse 436 market data Tables and 54 Figures spread through 369 Pages and in-depth TOC on “Gene Expression Analysis Market by Product (Reagents, Enzymes, kits, DNA Chips, PCR, NGS, DNA Microarray), Service (RNA Sequencing, Bioinformatics), Application (Drug discovery & development, clinical diagnostics), End User – Global Forecast to 2029

Gene Expression Analysis Market in terms of revenue was estimated to be worth $4.2 billion in 2024 and is poised to reach $6.2 billion by 2029, growing at a CAGR of 8.1% from 2024 to 2029 according to a new report by MarketsandMarkets™. The gene expression analysis market is experiencing significant growth due to several key factors. Firstly, the increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders is driving the demand for advanced diagnostic and therapeutic solutions. Gene expression analysis plays a crucial role in understanding the genetic basis of these diseases, enabling personalized medicine approaches for more effective treatments. However, the high cost of instruments & consumables and concerns associated with data privacy and security are expected to restrain the market growth during the forecast period.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=156613968

The assays & kits segment accounted for the largest share of reagents & consumables in the gene expression analysis market in 2023.

By reagents & consumables, the gene expression analysis market has been further categorized into assays & kits, enzymes, DNA chips, and others. Assays & kits accounted for the largest share of the gene expression analysis market in 2023. The increasing adoption of high-throughput technologies such as next-generation sequencing (NGS) and microarray analysis has boosted the demand for assays and kits. These technologies generate large amounts of data, and assays and kits help in streamlining the workflow, from sample preparation to data analysis.

The drug discovery & development application segment is expected to grow at a higher rate during the forecast period. 

Based on technology, the gene expression analysis market has been segmented into drug discovery & development, clinical diagnostics, and other applications. In 2023, the drug discovery & development segment accounted for the largest share of the gene expression analysis market and is expected to grow at a higher growth rate during the forecast period of 2024-2029. The share share of drug discovery & development application is attributed to gene expression analysis is instrumental in the preclinical and clinical stages of drug development. In preclinical studies, researchers use gene expression profiling to assess the efficacy and safety of potential drug candidates. This helps in selecting the most promising candidates for further development, reducing the time and cost associated with drug discovery.

The pharmaceutical & biotechnology companies segment accounted for the largest share of the end user segment in the gene expression analysis market in 2023.

Based on end user, the gene expression analysis market is segmented into pharmaceutical & biotechnology companies, academic & research institutes, and other end users. In 2023, pharmaceutical & biotechnology companies accounted for the largest share of the gene expression analysis market. As the pharmaceutical & biotechnology companies heavily rely on understanding how genes are expressed in various disease states to identify potential drug targets. Gene expression analysis helps in pinpointing genes that are upregulated or downregulated in diseases, providing valuable insights into disease mechanisms and potential therapeutic interventions.

The North America region accounted for the largest share of the gene expression analysis market in 2023.

The gene expression analysis market is segmented into North America, Europe, Asia Pacific (APAC), Latin America (LATAM), the Middle East, and Africa. The North American region is observing rising investments in the field of drug discovery & development. Moreover, the need for advanced therapies due to the rising rate of chronic diseases such as cancer has contributed to the growth of the gene expression analysis market. The supportive government regulations in North America for the development of mAbs and biosimilars also contribute to market growth.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=156613968

Gene Expression Analysis Market Dynamics:

Drivers:

1.  Advancements in gene editing technologies

2.  Increasing funding initiatives for genomic research

3.  Growing preference for therapeutic applications

4.  Declining costs of sequencing technologies

Restraints:

1.  High cost of instruments & consumables

2.  Concerns associated with data privacy and security

Opportunities:

1.  High growth potential across non-clinical applications

2.  Machine learning and AI

3.  Growing focus on single-cell analysis

Challenge:

1.  Extensive timelines for product approval

2.  Data interpretation challenges

Key Market Players of Gene Expression Analysis Industry:

Key players in the gene expression analysis market are Thermo Fisher Scientific Inc (US), Bio-Rad Laboratories Inc. (US), Illumina Inc (US), QIAGEN (Netherlands), F. Hoffmann-La Roche (Switzerland), Revvity (US), PacBio (US), Agilent Technologies Inc (US), Oxford Gene Technology IP Limited (UK), BGI (China), Eurofins Scientific (Luxembourg), Standard BioTools (US), Oxford Nanopore Technologies plc (UK), GenScript (US), Takara Bio Inc (Japan), 10x Genomics (US), Zymo Research Corporation (US), Twist Bioscience (US), Promega Corporation (US), LGC Limited (UK), CD Genomics (US), NanoString Technologies Inc. (US), BioSpyder, Inc (US), Integrated DNA Technologies, Inc (US) and New England Biolabs (US).

The primary interviews conducted for this report can be categorized as follows:

  • By Respondent: Supply Side- 70% and Demand Side 30%
  • By Designation: Managers – 45%, CXOs and Directors – 30%, and Executives- 25%
  • By Region: North America -45%, Europe -20%, Asia-Pacific -20%, Latin America -10%, Middle East & Africa- 5%

Gene Expression Analysis Market – Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall gene expression analysis market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=156613968

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/gene-expression-analysis-market-156613968.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Gene Expression Analysis Market worth $6.2 billion by 2029

Electroceuticals/Bioelectric Medicine Market worth $33.6 billion by 2029

“Browse in-depth TOC on “Electroceuticals Market / Bioelectric Medicine Market” 457 – Tables 46 – Figures 400 – Pages”
Electroceuticals Market / Bioelectric Medicine Market in terms of revenue was estimated to be worth $23.9 billion in 2024 and is poised to reach $33.6 billion by 2029, growing at a CAGR of 7.0% from 2024 to 2029 according to a new report by MarketsandMarkets™

Electroceuticals Market / Bioelectric Medicine Market in terms of revenue was estimated to be worth $23.9 billion in 2024 and is poised to reach $33.6 billion by 2029, growing at a CAGR of 7.0% from 2024 to 2029 according to a new report by MarketsandMarkets™. The increasing elderly population and rising incidences of cardiovascular and neurological disorders worldwide are driving the market’s growth. Bioelectric medicine employs deep brain, vagus sacral, and transcutaneous electric nerve stimulators to treat these conditions. Additionally, the growing prevalence of arrhythmia, which requires the use of implantable cardioverter-defibrillators and cardiac pacemakers, is another growth driver. The market is also benefiting from the growing demand for non-invasive medical treatments, technological advancements, and a growing body of research demonstrating the efficacy of this technology. The development of new, more advanced electroceutical devices and therapies, such as implantable neurostimulators and transcutaneous electrical nerve stimulation (TENS) devices, is further propelling market growth.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=222053956

The cardiac pacemakers & implantable cardioverter defibrillators segment accounted for the largest share of the electroceuticals market, by product segment, in 2022

Based on product, the electroceuticals market is segmented into cardiac pacemakers & implantable cardioverter defibrillators, neuromodulators, cochlear implants, and retinal implants. The cardiac pacemakers & implantable cardioverter defibrillators segment accounted for the largest share of the electroceuticals market in 2022, primarily due to the increasing prevalence of cardiovascular disorders worldwide. Additionally, the rising incidence of sudden cardiac arrests, a growing elderly population, and advancements in product development are anticipated to drive market growth.

Non-invasive electroceutical devices segment to register the highest growth rate during the forecast period

The electroceuticals market is divided into two segments: implantable electroceutical devices and non-invasive electroceutical devices. In 2022, the noninvasive electroceutical devices segment experienced the highest growth rate. This growth is attributed to factors such as increased R&D investments by companies for novel product development and technological advancements in this segment.

Arrhythmia segment accounted for the largest share of the electroceuticals market, by product segment, in 2022

Based on application, the electroceuticals market is segmented into arrhythmia, chronic pain management, Parkinson’s disease, urine incontinence, depression, epilepsy, and others. In 2022, the arrhythmia segment emerged as the dominant force in the overall market. This dominance is fueled by the rising prevalence of arrhythmia, a condition often managed with implantable cardioverter-defibrillators and cardiac pacemakers.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=222053956

North America is the largest regional market for electroceuticals market

The global electroceuticals market is segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Among these regions, North America held the largest market share in the electroceuticals market in 2022. A significant share in North America can be attributed to the presence of major medical device manufacturers like Abbott and Boston Scientific Corporation. The region’s well-established healthcare system and access to advanced products have further propelled market growth. Following North America, Europe secured the second position, fueled by the increasing demand for innovative medical devices for treatment. The region’s robust healthcare infrastructure and the presence of major bioelectric medicine manufacturers are expected to continue driving market growth.

Key Market Players of Electroceuticals Market / Bioelectric Medicine Industry:

The major players in this market are Medtronic plc (Ireland), Boston Scientific Corporation (US), Abbott Laboratories, Inc. (US), LivaNova PLC (UK), Cochlear Ltd. (Australia), MicroPort Scientific Corporation (China), Sonova Group (Switzerland), Nevro Corp. (US), Axonics Modulation Technologies, Inc. (US), Neuronetics, Inc. (US), ElectroCore, Inc. (US), NeuroPace, Inc. (US), BIOTRONIK (Germany), Medico S.p.A. (Italy), Nurotron Biotechnology Co. Ltd. (US), MED-EL (Austria), Aleva Neurotherapeutics SA (Switzerland), NeuroSigma, Inc. (US), BioWave Corporation (US), Soterix Medical Inc. (US), Bioinduction (Amber Therapeutics) (UK), GiMer Medical (Taiwan), Cefaly (Belgium), BioControl Medical (Israel), and tVNS Technologies GmbH (Germany).

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1 – 28%, Tier 2 – 42%, and Tier 3 -30%
  • By Designation: C-level – 30%, D-level – 34%, and Others – 36%
  • By Region: North America – 46%, Europe – 25%, Asia Pacific – 18%, and Rest of the World -11%

Electroceuticals Market / Bioelectric Medicine Market – Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall electroceuticals market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, challenges, and opportunities.  

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=222053956

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/electroceutical-market-222053956.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Electroceuticals/Bioelectric Medicine Market worth $33.6 billion by 2029

Bioresorbable Polymers Market Applications, Growth, Size, Opportunities, Top Players, Trends, Segmentation, Regional Insights, Graph and Forecast to 2027

“Browse 247 market data Tables and 56 Figures spread through 225 Pages and in-depth TOC on “Bioresorbable Polymers Market””
Bioresorbable Polymers Market by Type (Polylactic acid (PLA), Polyglycolic acid (PGA), Polylactic-co-glycolic acid (PLGA), Polycaprolactone(PCL)), application (orthopedic devices, drug delivery), and Region – Global Forecast to 2027

The bioresorbable polymers market size is estimated to be USD 417 million in 2022 and is projected to reach USD 688 million by 2027 at a CAGR of 10.5% during the forecast period. The major drivers in this bioresorbable market are the growing demand for biocompatible medical devices, increasing surgical interventions, growing demand in drug delivery applications, and favorable reimbursement scenarios. The high cost of bioresorbable polymers compared to conventional polymers, lack of quality control in developing countries, and preference for minimally invasive surgeries are the major restraints for bioresorbable polymers. A significant opportunity in the resorbable polymers market is increasing the production of environmentally friendly products to meet the regulatory standards set by various environmental protection agencies. A stringent regulatory framework for medical devices and skilled personnel for the effective use of bioresorbable medical products remains a significant challenge in this market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=235258717 

The key market players profiled in the report include Corbion N.V. (The Netherlands), Evonik Industries AG(Germany), Foster Corporation (US), KLS Martin Group (Germany), DSM Biomedical (US), Inc, Ashland Global Holdings Inc. (US), Zeus Industrial Products(US), Inc, Seqens Group (France), REVA Medical, LLC (US), Poly-Med Incorporated (US), Bezwada Biomedical, LLC (US), Nomisma Healthcare Pvt. Ltd. (India), BMG Incorporated (Japan), Polysciences, Inc. (US), Huizhou Foryou Medical Devices Co., Ltd. (China), Musashino Chemical Laboratory, Ltd. (Japan), and Henan Xinghan Biotechnology Co. Ltd.(China).

Ashland Global Holdings Inc. is a global leader in specialty materials, with a broad portfolio in food & beverage, nutraceuticals, personal care & pharmaceutical, adhesives, architectural coatings, construction, and energy sectors. The company has 18 manufacturing and lab facilities in five countries and serves more than 100 countries. It distributes directly and through third-party distributors in regions such as North America, Europe, APAC, and the Middle East & Africa. The company focuses on innovation and developing new chemistries to resolve challenging problems in the medical sector. It works with integrity and respect for its customers, suppliers, and employees. The company provides an encouraging business environment and is open to new and innovative ideas

In March 2021, Ashland expanded its Viatel bioresorbable polymer manufacturing site and relocated Research & Development (R&D) from Dublin to the National Science Park, Mullingar, Ireland. The National Science Park in Mullingar has a network of innovative organizations, including Ireland’s leading research center for manufacturing solutions (IMR).

Request Sample Pages: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=235258717 

DSM Biomedical, Inc. is a subsidiary of Royal DSM. In June 2012, Royal DSM had acquired Kensey Nash Corporation, to strengthen its biomedical business. DSM Biomedical is one of the major manufacturers of polymers for medical implants. It offers a wide portfolio for bioabsorbable polymers, ceramic combinations, and composites. DSM Biomedical, Inc. is one of the world’s leading medical device development & manufacturing companies. It has a strong foothold in Europe, APAC, and North America. The company is investing in innovation and technology to provide customers with innovative solutions and is adopting new technologies. It covers various applications in the healthcare & hospital industry and has a robust global distribution network.

In September 2020, DSM announced a partnership with PBC Biomed, an Ireland-based medical device design and development company. This partnership will initially focus on developing regenerative bone adhesives for safe and cost-effective surgical procedures.

Read Our Trending Press Release Below:

Thermal Management Solutions Market

Low VOC Adhesive Market

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/bioresorbable-polymer-market-235258717.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Bioresorbable Polymers Market Applications, Growth, Size, Opportunities, Top Players, Trends, Segmentation, Regional Insights, Graph and Forecast to 2027